Grifols | GRFS - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Alaunos Therapeutics USD 400K 213K 2026-03
Arca Biopharma USD 6.67M 2.5M 2026-03
aTyr Pharma USD 2.76M 52.32M 2026-03
Bio Path USD 5.16M 260K 2026-03
Brainstorm Cell Therapeutics USD 7.32M 250K 2026-03
Capricor Therapeutics 3.93M 2.27M 2026-03
Cara Therapeutics USD 4.62M 1.4M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Grifols EUR 987.75M 47.87M 2025-12
Immunic USD 11.01M 873K 2026-03
Minerva Neurosciences USD 640K 305K 2025-12
Nektar Therapeutics USD 10.03M 744K 2026-03
Sangamo BioSciences USD 10.74M 7.46M 2025-06
TherapeuticsMD USD 143K 4K 2024-06